Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

SHA:600513 Revenue

Jiangsu Lianhuan Pharmaceutical had revenue of 797.12M CNY in the quarter ending September 30, 2025, with 53.81% growth. This brings the company's revenue in the last twelve months to 2.60B, up 11.26% year-over-year. In the year 2024, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.16B, down -0.63%.

• Revenue (ttm): 2.60B
• Revenue Growth: +11.26%
• P/S Ratio: 2.71
• Revenue / Employee: 1.87M
• Employees: 1,388
• Market Cap: 7.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.16B	-13.64M	-0.63%
Dec 31, 2023	2.17B	218.94M	11.20%
Dec 31, 2022	1.96B	309.34M	18.80%
Dec 31, 2021	1.65B	259.78M	18.74%
Dec 31, 2020	1.39B	95.71M	7.42%